Skip to main content
SpringerLink
Log in

Mesothelial Tumors, Pathology of the Peritoneum

  • Reference work entry
  • First Online:
Gynecologic Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 11 Accesses

Adenomatoid Tumor

Definition

Benign tumor of mesothelial origin.

Clinical Features

  • Incidence

    Infrequent. Adenomatoid tumors may disproportionately occur in immunocompromised patients.

  • Age

    Middle-aged patients, 28–68 years.

  • Sex

    Female and male.

  • Site

    In the female, adenomatoid tumors most commonly occur in the myometrium and the fallopian tube wall, but may rarely arise in the ovary, the omentum, the bowel mesentery, and the peritoneum. In the male, adenomatoid tumors may be located in the epididymis and less commonly in the spermatic cord, prostate, and ejaculatory ducts.

  • Treatment

    Usually an incidental finding at surgery for other indications.

  • Outcome

    This is a benign tumor.

Macroscopy

Well circumscribed and usually not exceeding 2 cm in size. Typically located subjacent to serosal surfaces.

Microscopy

Composed of pseudoglandular and pseudovascular spaces lined by flat to cuboidal cells (Fig. 1). The spaces may be small and anastomosing or large and pseudocystic. Occasionally,...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Further Reading

  • Alakus, H., Yost, S. E., Woo, B., French, R., Lin, G. Y., Jepsen, K., Frazer, K. A., et al. (2015). BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. Journal of Translational Medicine, 13, 122.

    Article  PubMed  PubMed Central  Google Scholar 

  • Alexander, H. R., Jr., Li, C. Y., & Kennedy, T. J. (2018). Current management and future opportunities for peritoneal metastases: Peritoneal mesothelioma. Annals of Surgical Oncology, 25, 2159–2164.

    Article  PubMed  Google Scholar 

  • Andrici, J., Jung, J., Sheen, A., D’Urso, L., Sioson, L., Pickett, J., Parkhill, T. R., et al. (2016). Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Human Pathology, 51, 9–15.

    Article  CAS  PubMed  Google Scholar 

  • Baker, P. M., Clement, P. B., & Young, R. H. (2005). Malignant peritoneal mesothelioma in women: A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. American Journal of Clinical Pathology, 123, 724–737.

    Article  PubMed  Google Scholar 

  • Berzenji, L., & Van Schil, P. (2018). Multimodality treatment of malignant pleural mesothelioma. F1000Research, 7, F1000 Faculty Rev-1681. https://doi.org/10.12688/f1000research.15796.1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cerruto, C. A., Brun, E. A., Chang, D., & Sugarbaker, P. H. (2006). Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Archives of Pathology & Laboratory Medicine, 130, 1654–1661.

    Article  Google Scholar 

  • Chen, X., Sheng, W., & Wang, J. (2013). Well-differentiated papillary mesothelioma: A clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology, 62, 805–813.

    Article  PubMed  Google Scholar 

  • Churg, A., & Galateau-Salle, F. (2012). The separation of benign and malignant mesothelial proliferations. Archives of Pathology & Laboratory Medicine, 136, 1217–1226.

    Article  Google Scholar 

  • Clement, P. B., Young, R. H., & Scully, R. E. (1996). Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. The American Journal of Surgical Pathology, 20, 1067–1080.

    Article  CAS  PubMed  Google Scholar 

  • Craig, J. R., & Hart, W. R. (1979). Extragenital adenomatoid tumor: Evidence for the mesothelial theory of origin. Cancer, 43, 1678–1681.

    Article  CAS  PubMed  Google Scholar 

  • Desmeules, P., Joubert, P., Zhang, L., Al-Ahmadie, H. A., Fletcher, C. D., Vakiani, E., Delair, D. F., et al. (2017). A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1/FUS-ATF1 fusions. The American Journal of Surgical Pathology, 41, 980–988.

    Article  PubMed  PubMed Central  Google Scholar 

  • Enomoto, L. M., Shen, P., Levine, E. A., & Votanopoulos, K. I. (2019). Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: Patient selection and special considerations. Cancer Management and Research, 11, 4231–4241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goode, B., Joseph, N. M., Stevers, M., Van Ziffle, J., Onodera, C., Talevich, E., Grenert, J. P., et al. (2018). Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Modern Pathology, 31, 660–673.

    Article  CAS  PubMed  Google Scholar 

  • Hoekstra, A. V., Riben, M. W., Frumovitz, M., Liu, J., & Ramirez, P. T. (2005). Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecologic Oncology, 98, 161–167.

    Article  PubMed  Google Scholar 

  • Hung, Y. P., Dong, F., Watkins, J. C., Nardi, V., Bueno, R., Dal Cin, P., Godleski, J. J., et al. (2018). Identification of ALK rearrangements in malignant peritoneal mesothelioma. JAMA Oncology, 4, 235–238.

    Article  PubMed  Google Scholar 

  • Joseph, N. M., Chen, Y. Y., Nasr, A., Yeh, I., Talevich, E., Onodera, C., Bastian, B. C., et al. (2017). Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Modern Pathology, 30, 246–254.

    Article  CAS  PubMed  Google Scholar 

  • Kerrigan, S. A., Turnnir, R. T., Clement, P. B., Young, R. H., & Churg, A. (2002). Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 patients. Cancer, 94, 378–385.

    Article  PubMed  Google Scholar 

  • Keshava, H. B., Tang, A., Siddiqui, H. U., Raja, S., Raymond, D. P., Bribriesco, A., Stevenson, J., et al. (2019). Largely unchanged annual incidence and overall survival of pleural mesothelioma in the USA. World Journal of Surgery, 43, 3239–3247.

    Article  PubMed  Google Scholar 

  • Kim, J., Bhagwandin, S., & Labow, D. M. (2017). Malignant peritoneal mesothelioma: A review. The Annals of Translational Medicine, 5, 236. https://doi.org/10.21037/tlcr.2018.10.04.

    Article  CAS  PubMed  Google Scholar 

  • Leblay, N., Lepretre, F., Le Stang, N., Gautier-Stein, A., Villeneuve, L., Isaac, S., Maillet, D., et al. (2017). BAP1 is altered by copy number loss, mutation, and/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas. Journal of Thoracic Oncology, 12, 724–733.

    Article  PubMed  Google Scholar 

  • Liu, S., Staats, P., Lee, M., Alexander, H. R., & Burke, A. P. (2014). Diffuse mesothelioma of the peritoneum: Correlation between histological and clinical parameters and survival in 73 patients. Pathology, 46, 604–609.

    Article  CAS  PubMed  Google Scholar 

  • Malpica, A., Sant’Ambrogio, S., Deavers, M. T., & Silva, E. G. (2012). Well-differentiated papillary mesothelioma of the female peritoneum: A clinicopathologic study of 26 cases. The American Journal of Surgical Pathology, 36, 117–127.

    Article  PubMed  Google Scholar 

  • Markowitz, S. (2015). Asbestos-related lung cancer and malignant mesothelioma of the pleura: Selected current issues. Seminars in Respiratory and Critical Care Medicine, 36, 334–346.

    Article  PubMed  Google Scholar 

  • Ordonez, N. G. (2013a). Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: A review and update. Human Pathology, 44, 1–19.

    Article  CAS  PubMed  Google Scholar 

  • Ordonez, N. G. (2013b). Value of claudin-4 immunostaining in the diagnosis of mesothelioma. American Journal of Clinical Pathology, 139, 611–619.

    Article  CAS  PubMed  Google Scholar 

  • Panou, V., Gadiraju, M., Wolin, A., Weipert, C. M., Skarda, E., Husain, A. N., Patel, J. D., et al. (2018). Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. Journal of Clinical Oncology, 36, 2863–2871.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pavlisko, E. N., Liu, B., Green, C., Sporn, T. A., & Roggli, V. L. (2020). Malignant diffuse mesothelioma in women: A study of 354 cases. The American Journal of Surgical Pathology, 44, 293–304.

    Article  PubMed  Google Scholar 

  • Pillappa, R., Maleszewski, J. J., Sukov, W. R., Bedroske, P. P., Greipp, P. T., Boland, J. M., Yi, E. S., et al. (2018). Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma. The American Journal of Surgical Pathology, 42, 256–263.

    Article  PubMed  Google Scholar 

  • Sangoi, A. R., McKenney, J. K., Schwartz, E. J., Rouse, R. V., & Longacre, T. A. (2009). Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Modern Pathology, 22, 1228–1235.

    Article  CAS  PubMed  Google Scholar 

  • Shrestha, R., Nabavi, N., Volik, S., Anderson, S., Haegert, A., McConeghy, B., Sar, F., et al. (2020). Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma. Cancers (Basel), 12, 1568.

    Article  CAS  PubMed  Google Scholar 

  • Stevers, M., Rabban, J. T., Garg, K., Van Ziffle, J., Onodera, C., Grenert, J. P., Yeh, I., et al. (2019). Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Modern Pathology, 32, 88–99.

    Article  CAS  PubMed  Google Scholar 

  • Sun, M., Zhao, L., Weng Lao, I., Yu, L., & Wang, J. (2019). Well-differentiated papillary mesothelioma: A 17-year single institution experience with a series of 75 cases. Annals of Diagnostic Pathology, 38, 43–50.

    Article  PubMed  Google Scholar 

  • Tamura, D., Maeda, D., Halimi, S. A., Okimura, M., Kudo-Asabe, Y., Ito, S., Sato, N., et al. (2018). Adenomatoid tumour of the uterus is frequently associated with iatrogenic immunosuppression. Histopathology, 73, 1013–1022.

    Article  PubMed  Google Scholar 

  • Tandon, R. T., Jimenez-Cortez, Y., Taub, R., & Borczuk, A. C. (2018). Immunohistochemistry in peritoneal mesothelioma: A single-center experience of 244 cases. Archives of Pathology & Laboratory Medicine, 142, 236–242.

    Article  CAS  Google Scholar 

  • Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., Cox, N. J., et al. (2011). Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics, 43, 1022–1025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xing, D., Banet, N., Sharma, R., Vang, R., Ronnett, B. M., & Illei, P. B. (2018). Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: A clinicopathologic study. Human Pathology, 72, 160–166.

    Article  CAS  PubMed  Google Scholar 

  • Yeh, C. J., Chuang, W. Y., Chou, H. H., Jung, S. M., & Hsueh, S. (2008). Multiple extragenital adenomatoid tumors in the mesocolon and omentum. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 116, 1016–1019.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

    Ben Davidson

  2. University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, Oslo, Norway

    Ben Davidson

  3. Division of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

    Bojana Djordjevic

  4. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

    Bojana Djordjevic

Authors
  1. Ben Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bojana Djordjevic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ben Davidson .

Editor information

Editors and Affiliations

  1. University of Medicine, Pharmacy, Sciences and Technology, “George E Palade” of Targu Mures, Targu Mures, Romania

    Simona Stolnicu

  2. Wayne State University, Detroit, MI, USA

    Rouba Ali-Fehmi

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Davidson, B., Djordjevic, B. (2023). Mesothelial Tumors, Pathology of the Peritoneum. In: Stolnicu, S., Ali-Fehmi, R. (eds) Gynecologic Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-97378-0_5674

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-97378-0_5674

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-97377-3

  • Online ISBN: 978-3-030-97378-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation